Part of the debate – in the Senedd at 4:41 pm on 17 January 2018.
Can I thank everybody who's contributed? Mike Hedges came straight in with the key point: this is not about legalising cannabis for recreational use. It's about ensuring that we trust our medical practitioners to provide legal prescriptions of cannabinoid drugs when patients can benefit. As Leanne Wood said, following effective evidence-based campaigns by MS Cymru and others, plus the cross-party group on neurological conditions, she has reached a principled position, that people are forced to use cannabis illegally to manage their symptoms, yet morphine—effectively heroin—is given on prescription. She said that this is about stopping people having to access an illegal raw drug—stopping people having to access an illegal raw drug. The wider debate about drugs is a different debate, because this is a health debate.
Caroline Jones said that cannabis has many medical benefits, but doesn't support the reclassification. She said that THC in cannabis can cause cognitive defects. Well, the marijuana plant is comprised of over 100 chemicals, or cannabinoids, with each having different physical effects. The two main chemicals are THC, which we referred to, the element that produces the high, and CBD, which does not produce any psychoactive effects. The particular point about medical cannabis is that it has a high CBD content, not a high THC content.
Mohammad Asghar said that over 100,000 people in the UK have MS, including 4,260 in Wales. He talked about the benefits of Sativex for spasticity, but also noted that lots of MS sufferers have to risk prosecution to manage their pain, and Wales must take the lead on this. Rhun ap Iorwerth said it is a simple matter: everything possible should be done to alleviate suffering. Cannabis use for medical and recreational purposes is not the same, and there are plenty of examples of existing prescription drugs being abused, but we don’t ban those.
The Cabinet Secretary’s speech was largely a response, I feel, to what I didn’t say, rather than an evidence-based response to what I did. He said that just because the United States, or some states in the US, do it, we don’t have to. But it’s not just the US; I listed many other examples across the globe. The point is that this is becoming the norm globally. We’re getting left behind. And he said that this motion raises more questions than answers. So, could I ask him: would he agree to meet with medical advisers, endorsing the comment made by Leanne Wood, including Professor Barnes, to discuss the evidence to date on cannabis for medicinal use? We’ve all heard about the work of the all-party parliamentary group. Well, Professor Michael Barnes found that, overall, there is good evidence for the use of cannabis in many important conditions that affect many thousands of disabled people in the UK. He said:
‘Generally, cannabis and cannabis products are safe and well tolerated. It is clear from this review that cannabis does have medicinal value’.
And he said:
‘We consider that the evidence firmly suggests that cannabis should be a legal product for medicinal use, as long as the quality of the product is guaranteed and the supply chain secured and that medical users are, as far as possible and practicable, entered into proper long term studies of both efficacy and side effects.’
That is what we are proposing.
On the basis of his report, the States of Jersey said it formed the basis for planned changes across both Jersey and Guernsey. So, again, I will conclude by asking the health Secretary: will the Welsh Government agree to meet medical advisers, including Professor Barnes, to discuss the evidence to date on cannabis for medical use and to look at the detailed work across seven months by our colleagues in Westminster and the very detailed and evidenced-based international study that Professor Barnes conducted? Thank you very much.